Skip to main content

Chronic Spasticity News (Page 3)

Botox (onabotulinumtoxinA) Receives FDA Approval for Treatment of Upper Limb Spasticity in Adults

IRVINE, Calif.--(BUSINESS WIRE)--Mar 10, 2010 - Allergan, Inc. today announced that the United States Food and Drug Administration (FDA) has approved Botox (onabotulinumtoxinA) for the treatment of...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related drug support groups

baclofen, Botox